Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
05/18/1989 | WO1989004305A1 Quinoline derivatives as antagonists of leukotriene d4 |
05/18/1989 | WO1989004304A1 Quinoline derivatives as antagonists of leukotriene d4 |
05/18/1989 | WO1989004303A1 Quinoline derivatives as antagonists of leukotriene d4 |
05/18/1989 | WO1989004299A1 Furan and pyrrole containing lipoxygenase inhibiting compounds |
05/18/1989 | WO1989004178A1 New therapeutical use of h2-receptor-blocking compounds |
05/18/1989 | WO1989004173A1 Acceleration of bone formation with gm-csf |
05/18/1989 | DE3737703A1 Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum Neutrophil-activating polypeptide moved to its production and its use as a drug and diagnostic use |
05/17/1989 | EP0316279A2 Ester derivatives of azacyclic hydroxycompounds |
05/17/1989 | EP0316022A2 Tricyclic compounds |
05/17/1989 | CN1032935A Fluorinated arachidonic acid derivatives |
05/16/1989 | US4831155 Physostigmine derivatives with acetylcholinesterase inhibition properties, and manufacture |
05/16/1989 | US4831046 Tetrazole derivatives of 1,3-dioxane and thromboxane A2 antigonizing use thereof |
05/16/1989 | US4831045 Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient |
05/16/1989 | US4831043 Dopaminergic benzimidazol-2-ones |
05/16/1989 | US4831024 Method to prevent neonatal jaundice |
05/16/1989 | US4830853 Ascorbic acid, sodium ascorbate |
05/16/1989 | CA1254217A1 Diaryldiazolylmethanes |
05/16/1989 | CA1254207A1 THERAPEUTICALLY USEFUL IMIDAZO¬1,2-.alpha.|PYRIDINE DERIVATIVES |
05/16/1989 | CA1254205A1 6-amidino-2-naphthyl benzoate compounds |
05/16/1989 | CA1254203A1 Dialkylaminotetrahydroquinazoline |
05/10/1989 | EP0315399A2 Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same |
05/10/1989 | EP0315390A2 Novel 4-oxobenzotriazines and 4-oxoquinazolines |
05/10/1989 | EP0315349A1 Phospholipase A2 inhibiting compositions and their use |
05/10/1989 | EP0315219A2 Pharmaceutical compositions |
05/10/1989 | EP0315218A2 Pharmaceutical compositions |
05/10/1989 | EP0315166A2 Fluorinated arachidonic acid derivatives |
05/10/1989 | EP0314863A2 Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation |
05/10/1989 | CN1032738A Pharmaceutical composition for piperidinoalkanol-decongestant combination |
05/09/1989 | US4829058 Inhibitors of bacteria, mycobacteria and plasmodia |
05/09/1989 | US4828827 Process for augmenting soft tissue with cross-linked polyvinyl pyrrolidone |
05/09/1989 | CA1253999A1 .alpha.-AMINOBORONIC ACID PEPTIDES |
05/09/1989 | CA1253871A1 Diphenylmethylimine derivatives |
05/09/1989 | CA1253862A1 N,n-disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo- ¬2,1-b|quinazolinyl)-oxyalkylamides |
05/05/1989 | WO1989003873A1 Regulation of cell proliferation and differentiation using peptides |
05/05/1989 | WO1989003838A1 Acyl deoxyribonucleoside derivatives and uses thereof |
05/05/1989 | WO1989003836A1 Factors associated with essential hypertension |
05/05/1989 | WO1989003833A1 IMIDAZO(1,2-a)(PYRIDAZINES OR PYRAZINES) FOR TREATMENT OF DISEASES RELATED TO BONE LOSS |
05/05/1989 | WO1989003830A1 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss |
05/05/1989 | WO1989003829A1 Omeprazole for treatment of diseases related to bone loss |
05/05/1989 | WO1989003724A1 Method for introducing and bonding gas into water, apparatus for carrying out the method and water produced by the method |
05/05/1989 | WO1989003692A1 Treating premenstrual or late luteal phase syndrome |
05/05/1989 | WO1989003682A1 Benzothiazine dioxide derivatives |
05/03/1989 | EP0314464A1 Thiophene derivatives |
05/03/1989 | EP0314387A1 Stabilized pergolide compositions |
05/03/1989 | EP0314329A1 Benzothiazine dioxide derivatives |
05/03/1989 | EP0314154A2 Tetrahydrofuro- and thieno(2,3-c)pyridines, their use as a medicament and process for their preparation |
05/03/1989 | EP0314042A2 Novel copolymers and superoxide dismutase modified with said copolymers |
05/03/1989 | EP0314015A1 Method for introducing and bonding gas into water, apparatus for carrying out the method and water produced by the method |
05/03/1989 | EP0313874A2 Disulfur analogs of LL-E33288 antitumor agents |
05/03/1989 | EP0313873A1 Targeted forms of methyltrithio antitumor agents |
05/03/1989 | EP0313847A2 Non-peptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents |
05/03/1989 | EP0313846A2 Method for controlling chronic respiratory disease, and necrotic enteritis in avian species |
05/03/1989 | EP0313697A1 Leukotriene antagonists |
05/02/1989 | US4827017 Novel carbacyclins, processes for their production and their use as medicinal agents |
05/02/1989 | US4826990 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
05/02/1989 | US4826987 Pyridyl and quinoline derivatives |
05/02/1989 | US4826969 Bicyclic naphthalenic derivatives, a process for preparing the same and human or veterinary medicines and cosmetic compositions containing said derivatives |
05/02/1989 | US4826963 Dissolving absorption |
05/02/1989 | US4826878 New derivatives of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4-oxobutanoic acids with antagonistic activity towards cholecystokinin |
05/02/1989 | US4826853 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use |
05/02/1989 | US4826852 Novel ergolinyl compounds nitrogen-substituted in the 8-position, useful for treating dopamine deficiency |
05/02/1989 | US4826839 Gastrointestinal disorders, headaches |
05/02/1989 | US4826814 Inhibitors of angiotensin converting enzyme |
05/02/1989 | US4826811 Crosslinked, pyridoxylated hemoglobin free of tetramers |
05/02/1989 | CA1253500A1 Acylaminoalkanoyl urethanes or thiourethanes |
05/02/1989 | CA1253494A1 12,16 - DIFLUOROPROSTAGLANDIN F.SUB.2.alpha. COMPOUNDS |
05/02/1989 | CA1253493A1 Bicycloheptane substituted ethers |
04/27/1989 | DE3835099A1 Pharmazeutische zusammensetzung Pharmaceutical composition |
04/26/1989 | EP0313515A1 A polypeptide growth factor from milk |
04/26/1989 | EP0313002A2 Phenyl glycines for use in reducing neurotoxic injury |
04/26/1989 | EP0312858A1 Heterocyclic derivatives, their preparation and radiosensitizing agents and antiviral agents comprising same as their active component |
04/26/1989 | EP0312543A1 $i(IN SITU) ACTIVE COMPOUND ASSEMBLY |
04/25/1989 | US4824959 Intermediates for antihypercholesterolemic tetrazole compounds |
04/25/1989 | US4824840 Carbostyril derivatives and pharmaceutical preparations containing same |
04/25/1989 | US4824834 Treating gout |
04/25/1989 | US4824832 Sulfhydryl containing tricyclic lactams and their pharmacological methods of use |
04/20/1989 | WO1989003214A1 Method to prevent neonatal jaundice |
04/20/1989 | WO1989003211A1 Treatment of cocaine addiction |
04/19/1989 | EP0312265A2 Adhesive compositions, controlled release compositions and transdermal drug delivery device |
04/19/1989 | EP0312208A1 Gel formulations containing growth factors |
04/19/1989 | EP0312132A2 Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine |
04/19/1989 | CN1032443A Method for preparing phospinic acids used in preparing ace inhibitors and intermediates produced thereby |
04/18/1989 | US4822894 Pure cis enantiomers of fused pyrrole ring carboxylates |
04/18/1989 | US4822879 Lower toxicity than griseolic acid itself |
04/18/1989 | US4822823 Improved water solubility by adding cyclodextrin derivatives |
04/18/1989 | US4822817 Remedy for bone disease |
04/18/1989 | US4822812 Antidepressant-monoamine oxidase inhibitor |
04/18/1989 | US4822811 Carbazole lipoxygenase inhibiting compounds, compositions and use |
04/18/1989 | US4822804 5,6,7,-trinor-4,8-inter-m-phenylene 2-nor PGI2 derivatives and anti-ulcer, anti-thrombotic and anti-hypertensive pharmaceutical compositions containing them |
04/13/1989 | DE3833603A1 (thien-2-yl-methyl)-thioharnstoffderivate, verfahren zur herstellung derselben und diese enthaltende beifuttermittel, futtermittelkonzentrate und futtermittel (Thien-2-yl-methyl) -thioharnstoffderivate, process for production thereof and containing them beifuttermittel, animal nutrition and animal feed concentrates |
04/12/1989 | EP0311447A1 Aromatase inhibiting 4(5)-imidazoles |
04/12/1989 | EP0311138A2 Compounds for the induction of in vivo and vitro production of cytokines |
04/12/1989 | EP0311068A2 Polyamine derivatives as antineoplastic agents |
04/12/1989 | EP0311067A1 Pharmaceutical composition for piperidinoalkanol-decongestant combination |
04/12/1989 | EP0311032A1 Synergistic intraocular pressure lowering combinations |
04/12/1989 | EP0311012A2 Glaucoma treatment |
04/12/1989 | EP0310918A2 Peptide-like amino-acid derivatives |
04/12/1989 | EP0310622A1 Anti-inflammatory compositions. |
04/11/1989 | US4820836 Prostacyclin (PGI2) analogues |
04/11/1989 | US4820834 Gastrin, cholecystokinin antagonists |